AstraZeneca Pharma India Ltd.

NSE: ASTRAZEN | BSE: 506820 | ISIN: INE203A01020 | Industry: Pharmaceuticals
| Expensive Performer
9288.5000 161.50 (1.77%)
NSE Jul 09, 2025 15:31 PM
Volume: 37,170
 

logo
AstraZeneca Pharma India Ltd.
edited 27 Nov 2020
9288.50
1.77%
Business Standard
AstraZeneca is likely to run an additional global trial to assess the efficacy of its COVID-19 vaccine using a lower dosage amid questions over the results from its late-stage study
Number of FII/FPI investors increased from 147 to 164 in Mar 2025 qtr.
Sputnik V to AstraZeneca: 'Combine your vaccine with ours to boost efficacy'
Business Today | 27 Nov 2020 9 more
More from AstraZeneca Pharma India Ltd.
Recommended
Market closes lower, Sarda Energy gets CSPDCL nod to source power from Rehar-1 hydro project
Trendlyne Marketwatch | 09 Jul 2025, 05:47PM
All in the family: Bajaj, Murugappa, Mahindra & Tata Group stocks outpace the benchmark
The Baseline | 09 Jul 2025, 04:24PM
Five stocks to buy from analysts this week - July 08, 2025
The Baseline | 08 Jul 2025, 05:56PM